Clinical Research Directory
Browse clinical research sites, groups, and studies.
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
Sponsor: Hong Kong Sanatorium & Hospital
Summary
This study is testing a shorter treatment method for prostate cancer using proton therapy (PT), which is very precise and may cause fewer side effects compared to traditional radiation. However, it is expensive and not easily accessible for many patients. To make it more affordable and accessible, this study is testing whether 2 fractions of stereotactic body proton therapy (SBPT) can be as safe and effective as the standard 5 sessions.
Official title: 2-fraction Stereotactic Body Proton Therapy (SBPT) With Magnetic Resonance Imaging (MRI) Guidance in Localized Prostate Cancer: A Single-arm Phase II Non-randomized Trial
Key Details
Gender
MALE
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2025-09-01
Completion Date
2033-06-02
Last Updated
2026-03-16
Healthy Volunteers
No
Interventions
Pencil Beam Proton Therapy Treatment Machine
2 fractions will be delivered to treat low- or intermediate- risk prostate cancer
Locations (1)
Hong Kong Sanatorium and Hospital
Hong Kong, Hong Kong